May 25 2012 - Pharmascience and Bellus Health Announce Closing of Transaction
We are very pleased to announce that earlier today Pharmascience and Bellus concluded the previously announced strategic partnership between the two companies whereby Pharmascience will pay a total of id="mce_marker"7.25 million to Bellus, for a 10.4% ownership stake in Bellus.
April 5 2012 - Pharmascience Enters In a Strategic Partnership with Bellus Health
Pharmascience Inc has proudly entered into a strategic partnership and financing with Bellus Health ("Bellus"), a public company, whereby Pharmascience will own over 10% of Bellus
May 27 2011 - Pharmascience Acquires Aegera Therapeutics
Pharmascience is pleased to announce the acquisition of Aegera Therapeutics Inc., a clinical-stage biotechnology company based in Montreal.
May 16 2011 - Pharmascience Opens New Laboratory & Production Facilities
In May 2011, Pharmascience, the largest generic pharmaceutical company in Quebec, inaugurated its new Montreal laboratory and production facilities, representing an investment of nearly $40 million